CD8+ cells are often considered to have anti-tumor effects, but in our study, we found that patients in the high-ICPS risk score group had higher levels of CD8+ T cell infiltration, which is inconsistent with previous prognoses and has piqued our interest 54. This evidence concerns the gene CD8A and neoplasm.